Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference

Geron Corporation (Nasdaq: GERN) announced that Dr. John A. Scarlett, Chairman and CEO, will participate in a virtual fireside chat at the B. Riley Securities 3rd Annual Virtual Oncology Conference on January 18 at 1 p.m. ET.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the B. Riley Securities 3^rd Annual Virtual Oncology Conference on January 18 at 1 p.m. ET.

A live webcast of the presentation will be available through the Investor Relations section of Geron’s website under Events. Following the presentation, the webcast will be archived and available for replay for a period of 30 days.

About Geron

Geron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230112005297/en/

Aron Feingold
Investor and Media Relations
investor@geron.com
media@geron.com

Source: Geron Corporation